Advancing Personalized Cancer Medicine Through Research
- Newest CPCT faculty member, Shailja Pathania PhD, seeks new clues to hereditary breast cancer. (posted 3/30/17)
- The CPCT Genomics Core will be closed November 24th and 25th in observance of the holiday. Please also note that our iLab service will be unavailable Friday, November 25th from 10:00 pm - Saturday, November 26th 12:00 pm Eastern Time. (Posted 11/23/16)
- Click here for past announcements.
The Center for Personalized Cancer Therapy (CPCT) Genomics Core enables UMass Boston investigators and academic and industry collaborators to carry out basic and translational genomics research, leveraging cutting-edge technologies and next-generation sequencing capabilities for research and clinical applications. The Genomics Core helps investigators and clinicians analyze samples, identify genetic variants contributing to disease risk, and reveal complex mechanisms involved in human disease.